Thyroid Dysfunction and Its Association With Metabolic Dysfunction-Associated Fatty Liver Disease
Recruiting now
Conditions studied: Thyroid Dysfunction, Metabolic Dysfunction-Associated Fatty Liver Disease
In brief
This study aims to evaluate the prevalence of thyroid dysfunction and its association with metabolic dysfunction-associated fatty liver disease.
Key facts
- Study ID
- NCT06739330
- Run by
- Tanta University
- People needed
- 150
- Starts
- 2024-12-19
- Expected to finish
- 2025-05-01
- Last updated by the study team
- 2024-12-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Age ≥ 18 years.
- Both sexes.
- Patients with metabolic dysfunction-associated fatty liver disease (MAFLD).
You may not qualify if…
- History of thyroid disease or treatment (e.g., thyroid nodules, thyroid cancer, hypothyroidism, and hyperthyroidism).
- Patients with alcoholic liver disease take more than 40g of alcohol (or four units) per day.
- Viral hepatitis.
- Pregnant women.
Where it is running
- Tanta University — Tanta, El-Gharbia, Egypt (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.